Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 794-800

  Das, Prajnan ^a   Bhatia, Sumita ^a   Eng, Cathy ^a   Ajani, Jaffer A ^a   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a   Chang, George J ^a   Bhosale, Priya ^a   Delclos, Marc E ^a   Krishnan, Sunil ^a   Janjan, Nora A ^a   Crane, Christopher H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anal cancer; Chemoradiation; Predictive factors; Radiation therapy; Recurrence

Indexed keywords

CELLS; CHEMOTHERAPY; DISEASE CONTROL; RADIOTHERAPY; TUMORS;

ANAL CANCER; CHEMORADIATION; CONCURRENT CHEMOTHERAPY; PREDICTIVE FACTORS;

ONCOLOGY;

CAPECITABINE; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 34249319133     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.052     Document Type: Article

References (25)

1. Nigro N.D., Seydel H.G., Considine B., et al. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51 (1983) 1826-1829
2. UKCCCR Anal Cancer Trial Working Party, and UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348 (1996) 1049-1054
3. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
4. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
5. Ajani J.A., Winter K.A., Gunderson L.L., et al. Intergroup RTOG 98-11: A phase III randomized study of 5-fluoruracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 24 (2006) 180s
6. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC cancer staging handbook. 6th ed. (2002), Springer-Verlag, New York, NY
7. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
8. Gerard J.P., Chapet O., Samiei F., et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: Experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 92 (2001) 77-84
9. Ferrigno R., Nakamura R.A., Dos Santos Novaes P.E., et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: Retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61 (2005) 1136-1142
10. Martenson J.A., Lipsitz S.R., Wagner Jr. H., et al. Initial results of a Phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 35 (1996) 745-749
11. Peiffert D., Giovannini M., Ducreux M., et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study. Ann Oncol 12 (2001) 397-404
12. Haddock M.G., and Martenson J.A. Anal carcinoma. In: Gunderson L.L., and Tepper J.E. (Eds). Clinical radiation oncology. 1st ed. (2000), Churchill Livingstone, Philadelphia, PA 747-761
13. Sischy B., Doggett R.L., Krall J.M., et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: Interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 81 (1989) 850-856
14. Cummings B.J., Keane T.J., O'Sullivan B., et al. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
15. Peiffert D., Bey P., Pernot M., et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37 (1997) 313-324
16. Grabenbauer G.G., Matzel K.E., Schneider I.H., et al. Sphincter preservation with chemoradiation in anal canal carcinoma: Abdominoperineal resection in selected cases?. Dis Colon Rectum 41 (1998) 441-450
17. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
18. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680
19. Graf R., Wust P., Hildebrandt B., et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 65 (2003) 14-22
20. Deniaud-Alexandre E., Touboul E., Tiret E., et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56 (2003) 1259-1273
21. Grabenbauer G.G., Kessler H., Matzel K.E., et al. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: Long-term results of 101 patients. Dis Colon Rectum 48 (2005) 1742-1751
22. Nilsson P.J., Svensson C., Goldman S., et al. Epidermoid anal cancer: A review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 61 (2005) 92-102
23. Chapet O., Gerard J.P., Riche B., et al. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
24. Rich T.A., Ajani J.A., Morrison W.H., et al. Chemoradiation therapy for anal cancer: Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 27 (1993) 209-215
25. Hung A., Crane C., Delclos M., et al. Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index. Cancer 97 (2003) 1195-1202